Alterations of LKB1 and KRAS and risk of brain metastasis: comprehensive characterization by mutation analysis, copy number, and gene expression in non-small-cell lung carcinoma.
about
Liquoral liquid biopsy in neoplastic meningitis enables molecular diagnosis and mutation tracking: a proof of concept.Modulation of NF-κB/miR-21/PTEN pathway sensitizes non-small cell lung cancer to cisplatinLKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitmentCUG-binding protein 1 (CUGBP1) expression and prognosis of brain metastases from non-small cell lung cancerSynergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer.KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis.STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment.Targeting metabolism and AMP-activated kinase with metformin to sensitize non-small cell lung cancer (NSCLC) to cytotoxic therapy: translational biology and rationale for current clinical trials.Low LKB1 Expression Results in Unfavorable Prognosis in Prostate Cancer Patients.Metabolic advantages and vulnerabilities in brain metastases.Lung cancer-associated brain metastasis: Molecular mechanisms and therapeutic options.[Research Progress of KRAS Mutation in Non-small Cell Lung Cancer].Potential Molecular Signatures Predictive of Lung Cancer Brain Metastasis.
P2860
Q33778007-C9D8C4FB-8773-4A01-85F4-967E87FD3158Q35584008-09FCF2B3-8374-4DD0-B314-DA2BE19CB18EQ36266500-61A3D891-E2D1-4BC9-BCCB-1FC4042BF7E1Q36477740-EADE2738-38BE-4F00-A4DA-0DB78BB88BDEQ37277324-62A5C10C-1EDA-453C-AEAF-215BB02B30EAQ37554470-C0CACC21-8642-42D1-94BB-926D2D35C01EQ38731119-282EEBD0-745C-4E48-A84F-9994EA3185CAQ41339882-A5B8941F-4D89-4347-874A-BE2F510C7FA6Q43141644-F6B32EC6-6151-46B5-9423-82CB22CF677AQ47566658-2CB5B385-6FC9-43B0-B9B9-4E6A33D0AD65Q52087016-ED18E894-EC4E-4E76-891B-96C20DB36E22Q54109659-BC16BB4D-40CC-46AA-B54A-A88A6EC299B4Q55345918-E99AD8F6-1C81-4DA7-BC92-E75E22165FD8
P2860
Alterations of LKB1 and KRAS and risk of brain metastasis: comprehensive characterization by mutation analysis, copy number, and gene expression in non-small-cell lung carcinoma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Alterations of LKB1 and KRAS a ...... non-small-cell lung carcinoma.
@ast
Alterations of LKB1 and KRAS a ...... non-small-cell lung carcinoma.
@en
type
label
Alterations of LKB1 and KRAS a ...... non-small-cell lung carcinoma.
@ast
Alterations of LKB1 and KRAS a ...... non-small-cell lung carcinoma.
@en
prefLabel
Alterations of LKB1 and KRAS a ...... non-small-cell lung carcinoma.
@ast
Alterations of LKB1 and KRAS a ...... non-small-cell lung carcinoma.
@en
P2093
P2860
P50
P1433
P1476
Alterations of LKB1 and KRAS a ...... non-small-cell lung carcinoma
@en
P2093
Alden M Parsons
Benjamin E Haithcock
Carrie B Lee
D Neil Hayes
Juneko E Grilley-Olson
Leigh B Thorne
Matthew D Wilkerson
Michele C Hayward
Patrick Roberts
P2860
P304
P356
10.1016/J.LUNGCAN.2014.08.013
P577
2014-08-30T00:00:00Z